SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-003144
Filing Date
2023-05-10
Accepted
2023-05-10 15:41:52
Documents
47
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20230331_10q.htm   iXBRL 10-Q 530416
2 EXHIBIT 31.1 ex_513433.htm EX-31.1 13319
3 EXHIBIT 31.2 ex_513434.htm EX-31.2 13211
4 EXHIBIT 32.1 ex_513435.htm EX-32.1 10421
  Complete submission text file 0001171843-23-003144.txt   2945534

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20230331.xsd EX-101.SCH 26888
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20230331_cal.xml EX-101.CAL 25345
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20230331_def.xml EX-101.DEF 188730
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20230331_lab.xml EX-101.LAB 171905
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20230331_pre.xml EX-101.PRE 207812
41 EXTRACTED XBRL INSTANCE DOCUMENT xbit20230331_10q_htm.xml XML 330429
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 23906068
SIC: 2834 Pharmaceutical Preparations